术前静脉注射地塞米松对晚期老年全膝关节置换术患者疼痛与恶心的影响:一项随机双盲试验
这项单中心随机双盲两臂研究纳入160例75岁以上拟行全膝关节置换术患者,比较术前单次静脉注射地塞米松10 mg与生理盐水对术后疼痛和恶心呕吐的影响。结果显示地塞米松组术后24小时静息数字评分量表中位分更低(4分 vs 5分,P<0.001),恶心呕吐发生率更低(16.9% vs 40.8%,P=0.002)。
要点
- 75岁以上全膝关节置换患者术前静脉注射地塞米松10 mg可降低术后24小时静息疼痛评分和恶心呕吐发生率。
- 地塞米松组术后24小时、36小时和1周运动痛评分及白细胞介素-6、C反应蛋白水平均显著低于对照组。
- 两组阿片类药物总消耗量、补救镇痛药用量及感染和伤口延迟愈合发生率无显著差异。
核心结论
- 对相对健康的晚期老年(美国麻醉医师协会体能状态I至II级)全膝关节置换患者,术前静脉注射地塞米松10 mg显著减轻术后疼痛和恶心呕吐,且不增加伤口并发症或感染。
- 作者提示将结果外推至合并症更多的人群时需谨慎,并指出需进一步研究评估长期结局和更广泛适用性。
研究设计与样本
- 单中心、双盲、两臂随机对照试验,比较术前静脉注射地塞米松10 mg与生理盐水。
- 计划纳入75岁以上拟行全膝关节置换术患者,共160例随机分组,153例完成分配干预(地塞米松组77例,对照组76例)。
- 所有受试者接受多模式镇痛,包括股神经阻滞、环氧化酶抑制剂、局部麻醉药浸润及阿片类药物患者自控静脉镇痛。
主要发现
- 术后24小时地塞米松组静息数字评分量表中位分4分(四分位距3至4)vs 对照组5分(四分位距4至6),P<0.001。
- 术后24小时地塞米松组恶心呕吐发生率16.9% vs 对照组40.8%,P=0.002。
- 地塞米松组术后24小时、36小时和1周运动痛评分及血清白细胞介素-6和C反应蛋白水平显著低于对照组(均P<0.05)。
- 两组阿片类药物总消耗量、补救镇痛药用量及感染和伤口延迟愈合发生率无显著差异。
关键数值与推荐
- 主要结局为术后24小时静息数字评分量表评分和恶心呕吐发生率。
- 次要结局包括运动痛评分、阿片类药物消耗量、恶心严重程度、血糖、炎症因子及副作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出将结果外推至合并症更多的人群时需谨慎。
- 作者指出需进一步研究评估长期结局和更广泛适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total knee arthroplasty (TKA) is a standard procedure in elderly patients; however, postoperative pain and postoperative nausea and vomiting (PONV) remain challenging. This study aimed to evaluate the effects of a single preoperative intravenous (IV) dose of dexamethasone (10 mg) on postoperative pain and PONV in older patients (≥ 75 years) undergoing TKA. METHODS: A single-center, double-blind, two-arm study compared preoperative dexamethasone (10 mg) versus saline on postoperative pain and PONV in planned TKA patients over 75 years old. Subjects received multimodal analgesia, including femoral nerve block, cyclooxygenase inhibitors, local anesthetic infiltration, and patient-controlled IV analgesia with opioids. The primary outcomes were resting numeric rating scale score and incidence of PONV at 24 hours. Secondary outcomes included motion pain scores, opioid consumption, nausea severity, blood glucose, inflammatory factors, and side effects. RESULTS: There were 160 patients randomized; 153 completed the allocated interventions (dexamethasone n = 77, control n = 76). At 24 hours postoperatively, the dexamethasone group had a lower median resting numeric rating scale score (4 interquartile range 3 to 4] versus 5 [interquartile range 4 to 6], P < 0.001) and a lower incidence of PONV (16.9 versus 40.8%, P = 0.002) compared with controls. Select secondary outcomes showed significantly lower motion pain scores (24 hours, 36 hours, and one week) and reduced serum interleukin-6 and C-reactive protein levels in the dexamethasone group (all P < 0.05). No significant difference was noted in total opioid consumption, rescue analgesics, or incidence of infection and delayed wound healing between groups. CONCLUSIONS: Preoperative administration of 10 mg IV dexamethasone to relatively healthy late-stage elderly patients (American Society of Anesthesiologists Physical Status I to II) undergoing TKA significantly reduced postoperative pain and PONV without increasing wound complications or infections. However, caution should be exercised when extrapolating these results to more comorbid populations, and further research is needed to assess long-term outcomes and broader applicability.
引用
- Xu C, Wang X, Wang M, et al. Implication of Preoperative Intravenous Dexamethasone on Pain and Nausea in Late-Stage Elderly Total Knee Arthroplasty Patients: A Randomized Double-Blind Trial. J Arthroplasty. 2025. PMID: 40414368. doi:10.1016/j.arth.2025.05.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。